We are live on ! Find out more
HC

Henshaw Capital Portfolio holdings

AUM $3.07B
1-Year Est. Return 40.85%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$2.4B
AUM Growth
+$14.3M
Cap. Flow
-$31.8M
Cap. Flow %
-1.32%
Top 10 Hldgs %
37.43%
Holding
309
New
7
Increased
36
Reduced
18
Closed
11

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$974K
2
BAH icon
Booz Allen Hamilton
BAH
+$939K
3
TFX icon
Teleflex
TFX
+$831K
4
LKQ icon
LKQ Corp
LKQ
+$721K
5
BABA icon
Alibaba
BABA
+$586K

Top Sells

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$11.4M
2
GEHC icon
GE HealthCare
GEHC
+$7.76M
3
PFE icon
Pfizer
PFE
+$7.24M
4
CVS icon
CVS Health
CVS
+$5.85M
5
XMTR icon
Xometry
XMTR
+$884K

Sector Composition

Rank Sector Weight
1 Technology 30.93%
2 Financials 13.51%
3 Industrials 13.33%
4 Consumer Discretionary 9.87%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRI icon
151
Thomson Reuters
TRI
$46B
$750K 0.03%
4,605
SPSC icon
152
SPS Commerce
SPSC
$3.06B
$749K 0.03%
4,072
BPMC
153
DELISTED
Blueprint Medicines
BPMC
$739K 0.03%
8,475
NVS icon
154
Novartis
NVS
$292B
$733K 0.03%
7,536
-707
-9% -$75.4K
GTLS
155
DELISTED
Chart Industries
GTLS
$725K 0.03%
3,797
EFOR
156
Everforth Inc
EFOR
$1.31B
$724K 0.03%
8,689
PTEN icon
157
Patterson-UTI
PTEN
$4.74B
$722K 0.03%
87,442
MFG icon
158
Mizuho Financial
MFG
$129B
$719K 0.03%
147,098
JJSF icon
159
J&J Snack Foods
JJSF
$1.67B
$713K 0.03%
4,594
LIN icon
160
Linde
LIN
$226B
$711K 0.03%
1,698
SUPN icon
161
Supernus Pharmaceuticals
SUPN
$2.54B
$710K 0.03%
19,641
+1,740
+10% +$61.3K
SSB icon
162
SouthState Bank Corp
SSB
$10.3B
$709K 0.03%
7,132
KRG icon
163
Kite Realty
KRG
$5.21B
$705K 0.03%
27,933
URBN icon
164
Urban Outfitters
URBN
$6.95B
$705K 0.03%
12,838
ZWS icon
165
Zurn Elkay Water Solutions
ZWS
$7.97B
$702K 0.03%
18,812
RACE icon
166
Ferrari
RACE
$73.9B
$687K 0.03%
1,617
LGND icon
167
Ligand Pharmaceuticals
LGND
$5.59B
$685K 0.03%
6,396
IX icon
168
ORIX
IX
$42.4B
$685K 0.03%
32,220
ESNT icon
169
Essent Group
ESNT
$6.19B
$679K 0.03%
12,481
SLAB icon
170
Silicon Laboratories
SLAB
$7.29B
$677K 0.03%
5,449
KTB icon
171
Kontoor Brands
KTB
$4.21B
$674K 0.03%
7,896
CNO icon
172
CNO Financial Group
CNO
$5.12B
$672K 0.03%
18,056
ROAD icon
173
Construction Partners
ROAD
$6.25B
$670K 0.03%
7,571
TEF
174
DELISTED
Telefonica
TEF
$666K 0.03%
165,769
IMAX icon
175
IMAX
IMAX
$2.76B
$664K 0.03%
25,929

Similar funds

Henshaw Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Henshaw Capital held 309 positions worth $2.4B, up 0.6% from $2.39B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Henshaw Capital's Q4 2024 filing shows 7 new, 36 increased, 18 reduced and 11 closed positions. Its largest new stake was Huazhu Hotels Group: 14,745 shares worth $487K. The largest sale was Union Pacific, an estimated $11.4M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.

  • Henshaw Capital's largest Q4 2024 buy was Huazhu Hotels Group: 14,745 shares worth $487K.
  • Henshaw Capital added most to ASML in Q4 2024, an estimated $974K increase.
  • Henshaw Capital's biggest Q4 2024 reduction was Union Pacific, cutting an estimated $11.4M.
  • Henshaw Capital fully exited GE HealthCare in Q4 2024, selling an estimated $7.76M.
  • Henshaw Capital's ten largest holdings make up 37% of its $2.4B portfolio in Q4 2024.
  • Henshaw Capital opened 7 new positions and closed 11 in Q4 2024.
  • Henshaw Capital's portfolio value rose 0.6% quarter-over-quarter to $2.4B.

Based on Henshaw Capital's 13F filing for Q4 2024, filed 28 May 2026.